Dr. Mary L. Bouxsein has been awarded the ESCEO-IOF Herbert Fleisch Medal in honor of her work in the field of skeletal fragility.
The annual award from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF), valued at 20,000 EUR, recognizes a researcher who has made outstanding and groundbreaking achievements in basic bone science.
The Medal was presented at an award ceremony held during the opening of the European Congress on Osteoporosis & Osteoarthritis (ESCEO13-IOF), in Rome, Italy.
Professor John A. Kanis, IOF President, said, "The ESCEO-IOF Herbert Fleisch Medal is named in honour of the late Professor Fleisch, a pioneer in osteoporosis research. We are pleased that Dr. Mary Bouxsein, whose work has considerably influenced knowledge about bone biomechanics, strength and microarchitecture has been named the winner of this prestigious award."
Dr. Bouxsein currently holds joint appointments as an Assistant Professor of Orthopedic Surgery at Harvard Medical School, adjunct Assistant Professor of Mechanical Engineering at Boston University, and is also a faculty member in the MIT-Bioastronautics Program. Her research focuses on understanding skeletal fragility from a biomechanics viewpoint, and includes studies using animal models and human cadaveric tissue, as well as clinical investigations. She also has a strong interest in the use of novel non-invasive imaging techniques to predict fracture risk and monitor response to osteoporosis therapies.
Dr. Bouxsein serves on the Committee of Scientific Advisors for the International Osteoporosis Foundation and is a Board Member of the International Bone and Mineral Society. She has published more than 145 peer-reviewed articles and book chapters and invited reviews.
The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization devoted to the prevention, diagnosis and treatment of osteoporosis and related diseases of bone, muscles and joints. IOF members, including committees of scientific researchers, patient, medical and research societies, and industry representatives from around the globe, share a common vision of a world without musculoskeletal diseases and fragility fractures. IOF now represents more than 200 societies in all regions of the world. http://www.
The European Society for Clinical & Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. http://www.